Molecular Partners AG engages in the provision of development of protein therapies for treatment of serious diseases like cancer and sight-threatening disorders. The firm has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics , and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.
Industry: Biological Products, (No Diagnostic Substances) Peers: AC Immune SA ADC Therapeutics SA CRISPR Therapeutics AG VectivBio Holding AG
Loading...
